2013 NCCN Oncology Curriculum: Metastatic Colorectal Cancer - Research Roundup

May 9, 2013

Presented by Dr. Alan P. Venook, MD, this live webinar will explore emerging treatments and research articles on metastatic colorectal cancer pipelines. In addition, the webinar will address the safety and efficacy of each emerging treatment, as well as their mechanism of action.

Target Audience

This educational program is designed to meet the educational needs of oncologists, pathologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.

Learning Objectives

Following this webinar, participants should be able to:

  • Describe recent advances in the management of patients with metastatic colorectal cancer
  • Outline the implications of recent research and practice changes to the clinical algorithms for patients with metastatic colorectal cancer
  • Outline the safety, efficacy, and mechanisms of action for each emerging treatment option in metastatic colorectal cancer
Additional information
Supporters: 

This activity is supported by educational grants from:

  • Bayer HealthCare Pharmaceuticals, Inc.
  • Genentech, USA
  • Lilly USA, LLC
  • sanofi-aventis U.S. and Regeneron Pharmaceuticals
Course summary
Available credit: 
  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Pharmacist
  • 1.00 Physician
Course opens: 
05/09/2013
Course expires: 
07/19/2013
Event starts: 
05/09/2013 - 2:00pm
Event ends: 
05/09/2013 - 3:00pm
Cost:
$0.00

Alan P. Venook, MD
UCSF Helen Diller Family Comprehensive Cancer Center

Available Credit

  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Pharmacist
  • 1.00 Physician

Accreditation Period

Course opens: 
05/09/2013
Course expires: 
07/19/2013

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

To complete this activity, users will need:

  • A device with an Internet connection
  • Adobe Reader or other PDF reader software for viewing/printing additional resource and certificate